Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing-Reference-Cited by-同舟云学术

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing

Published:2014-07-31 Issue:24 Volume:120 Page:3932-3939
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ferguson Sarah E.¹,Aronson Melyssa²,Pollett Aaron³,Eiriksson Lua R.⁴,Oza Amit M.⁵,Gallinger Steven²⁶,Lerner-Ellis Jordan³,Alvandi Zahra³,Bernardini Marcus Q.¹,MacKay Helen J.⁵,Mojtahedi Golnessa¹,Tone Alicia A.¹,Massey Christine⁷,Clarke Blaise A.³

Affiliation:

1. Division of Gynecologic Oncology; Department of Obstetrics and Gynecology; Princess Margaret Hospital/University Health Network, University of Toronto; Toronto Ontario Canada

2. Zane Cohen Centre for Digestive Diseases, Familial Gastrointestinal Cancer Registry, Mount Sinai Hospital; Toronto Ontario Canada

3. Department of Laboratory Medicine and Pathobiology; Faculty of Medicine, University of Toronto; Toronto Ontario Canada

4. Division of Gynecologic Oncology; Department of Obstetrics and Gynecology; Juravinski Hospital and Cancer Center, McMaster University; Hamilton Ontario Canada

5. Division of Medical Oncology; Faculty of Medicine, Princess Margaret Hospital/University Health Network, University of Toronto; Toronto Ontario Canada

6. Division of General Surgery; Princess Margaret Hospital/University Health Network, University of Toronto; Toronto Ontario Canada

7. Department of Biostatistics; Princess Margaret Hospital/University Health Network; Toronto Ontario Canada

Funder

Princess Margaret Hospital Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications;Lynch;Clin Genet,2009

2. Cancer risk in Lynch Syndrome;Barrow;Fam Cancer,2013

3. Risks of Lynch syndrome cancers for MSH6 mutation carriers;Baglietto;J Natl Cancer Inst,2010

4. French Cancer Genetics Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome;Bonadona;JAMA,2011

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical cytology in endometrial cancer patients with Lynch syndrome: opportunities for early detection and limitations;Journal of the American Society of Cytopathology;2024-08

2. Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study;Cancers;2024-07-15

3. Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection;International Journal of Molecular Sciences;2024-05-28

4. Molecular testing in gynecologic cancer;Diagnostic Molecular Pathology;2024

5. High-Grade Endometrial Carcinoma;Gynecologic and Obstetric Pathology;2024